Page last updated: 2024-11-01

ondansetron and Dermatitis, Eczematous

ondansetron has been researched along with Dermatitis, Eczematous in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research Excerpts

ExcerptRelevanceReference
"Ondansetron decreased pruritus intensity in prurigo simplex (four patients), asteatotic eczema (two patients), parapsoriasis en plaques, and pruritus of unknown origin (one patient each)."7.72[Therapy of pruritus associated with skin diseases with the serotonin receptor antagonist ondansetron]. ( Degitz, K; Schuh, T; Zenker, S, 2003)
"Ondansetron decreased pruritus intensity in prurigo simplex (four patients), asteatotic eczema (two patients), parapsoriasis en plaques, and pruritus of unknown origin (one patient each)."3.72[Therapy of pruritus associated with skin diseases with the serotonin receptor antagonist ondansetron]. ( Degitz, K; Schuh, T; Zenker, S, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zenker, S1
Schuh, T1
Degitz, K1

Other Studies

1 other study available for ondansetron and Dermatitis, Eczematous

ArticleYear
[Therapy of pruritus associated with skin diseases with the serotonin receptor antagonist ondansetron].
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2003, Volume: 1, Issue:9

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antipruritics; Dermatitis, Atopic; Eczema; Female; Fo

2003